TABLE 4.
Clinical status | Bile exosomal miR‐451a level | p value | Bile exosomal miR‐3619‐3p level | p value | ||
---|---|---|---|---|---|---|
High | Low | High | Low | |||
n = 22 | n = 23 | n = 22 | n = 23 | |||
Age | 76 | 76 | 0.67 | 76.5 | 76.0 | 0.10 |
Gender | ||||||
M:F | 15:7 | 17:6 | 0.67 | 13:9 | 19:4 | 0.08 |
Diseases | ||||||
dCCA | 10 | 13 | 10 | 13 | ||
GBC | 5 | 7 | 0.35 | 8 | 4 | 0.35 |
pCCA | 7 | 3 | 4 | 6 | ||
Stage | ||||||
I–II | 10 | 16 | 0.10 | 9 | 17 | 0.03 |
III–IV | 12 | 7 | 13 | 6 | ||
Treatment | ||||||
Surgery | 8 | 17 | 8 | 17 | ||
Chemotherapy | 5 | 3 | 0.03 | 5 | 3 | 0.03 |
BSC | 9 | 3 | 9 | 3 |
Abbreviations: BSC, best supportive care; dCCA, distal cholangiocarcinoma; F, female; GBC, gallbladder cancer; M, male; miR, microRNA; pCCA, perihilar cholangiocarcinoma.
The italic values, statistically significant.